Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The oral mucosal barrier is a complex system that protects the oral cavity from physical, chemical, and microbial insults. It primarily consists of stratified squamous epithelium (with or without keratinization), a basement membrane, and an underlying connective tissue (lamina propria). The barrier is further enhanced by the secretion of mucus rich in mucins, which lubricates and traps pathogens. While not a single druggable target, it is a crucial structure influencing overall oral health and a frequent site of drug action or drug-induced toxicity.
Not applicable as this is a system, not a single druggable target. However, many drugs aim to reinforce or repair the barrier, reduce inflammation, or address underlying causes of barrier damage.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oral Mucosal Barrier.